https://insights.citeline.com/hbw-insight/beauty/business/earnings/pg-sails-confidently-on-full-year-guidance-despite-inflation-supply-and-shipping-storms-UJLW6ELHAVAF5BCMRE7B3IZYR4/2026-04-24T21:48:37.911Zalways0.5https://insights.citeline.com/resizer/huMNKPPitusIYGjfis3XThGVvGk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2J54NT5FBJHILHGOY7U54ZONSM.jpghttps://insights.citeline.com/medtech-insight/business/earnings/edwards-lifesciences-raises-guidance-after-tavr-growth-leads-strong-q1-LHCPRTWN7VG3VIQX4ZAXUCJBOY/2026-04-24T21:44:22.02Zalways0.5https://insights.citeline.com/resizer/n_-nYRyXPKJ_nmAOChzNPBYs9s8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/P56POVKNURGQZAWDZXT4S7BTEE.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/fcrn-inhibitors-a-promising-pipeline-in-a-product-frontier-32GTAILE5RGBFPYRLSQEQA3OO4/2026-04-24T20:22:48.742Zalways0.5https://insights.citeline.com/resizer/apmg2YNC689adHZtSeUcOBjBV18=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GLW7VQMM3ZFCNLL2KJ3YS33Y3M.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/why-viridian-wants-in-on-fcrns-despite-being-late-to-the-game-V6EVRZKGBJCCHGBCIUBCPR2N3A/2026-04-24T20:22:08.952Zalways0.5https://insights.citeline.com/resizer/uXXGs90ONFywxfn0AbFuds6PlU4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/26JMYZ5IJVFYVPZV75AREJ6Q2A.jpghttps://insights.citeline.com/scrip/business/strategy/ceo-bayer-leaner-and-faster-but-not-out-of-the-woods-NPSIZFF7UVBMTEFE5IJNGAGZIQ/2026-04-24T20:19:54.63Zalways0.5https://insights.citeline.com/resizer/Ls7LOYqG-hvuVn2N9NtDc7gaZdM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YRTH362Q4BEFZEM4HYEYHPDW2M.jpghttps://insights.citeline.com/scrip/business/strategy/hansas-europe-miss-for-lead-drug-raises-us-launch-stakes-ZP4U7VQLWNDBXLLPBKLC6HUO3U/2026-04-24T20:19:03.278Zalways0.5https://insights.citeline.com/resizer/u_ZrORoDVefXcnQrzyPEfvlaNZc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JN6WNKH42BGSHFPRSPNQ2PXSYQ.jpghttps://insights.citeline.com/scrip/drug-pricing/expanding-direct-to-patient-options-bmspfizer-add-eliquis-to-cost-plus-drugs-portal-N5J7VR5YXNHJFHE7N232VBY56E/2026-04-24T20:17:29.876Zalways0.5https://insights.citeline.com/resizer/8g9UNKJaZqQtok09wWW7jXXRqRw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IEWQ65UUDZCSBOKR5GCOBPGYBM.jpghttps://insights.citeline.com/medtech-insight/business/r-and-d/clinical-trials/necteros-east-system-slows-aaa-growth-in-90-of-patients-over-two-years-SCBGVPRY7ZDC7MUBY6MUGG3CKE/2026-04-24T18:10:26.542Zalways0.5https://insights.citeline.com/resizer/Gikz3DwIbgHFyHE2rxb_aG47AtQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2MODR5LSJVCGPCYI4FZ72TMMTE.jpghttps://insights.citeline.com/medtech-insight/conferences/medcon/medcon-day-3-tarver-continues-to-hammer-home-use-of-medical-devices-S4OJJBATFRGQNOLMH7NOE27T3A/2026-04-24T17:45:53.378Zalways0.5https://insights.citeline.com/resizer/i6Spfhrcj_nprfIsXlUEhn7Hbfg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XH54E2LHBVHPRLVMPNORM423GM.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/recalls/abbott-monitors-freestyle-libre-3-in-india-as-class-i-recall-toll-reaches-860-injuries-E4KFZKDDE5E63CV2VZAOIAFVUA/2026-04-24T17:38:56.367Zalways0.5https://insights.citeline.com/resizer/0ASGS46Y7GUav1YkFQ3D4iM06-8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6G62P36RXFB77A6MRCQB4BYIVY.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/sanofis-tolebrutinib-gets-ema-backing-after-failing-to-win-over-us-regulators-BRGAODLQGVE7HPTOYSUCDBVWBM/2026-04-24T17:00:47.228Zalways0.5https://insights.citeline.com/resizer/HYYCc6maZg9sdOC2Q0J303oqdDw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/J7J426LVQBHJLEU4SRDXL37UP4.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/ema-clears-path-for-novartis-to-expand-market-for-sma-gene-therapy-itvisma-LMPNF6QTHZFFVCJZ665YDXPLEM/2026-04-24T16:59:04.918Zalways0.5https://insights.citeline.com/resizer/HMBCjbtQ_f3uqGiLc5dDLYhRoZE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5KQNPH3YFZAMJCO6W7NWZZ6OAQ.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/arrowheads-redemplo-nears-eu-approval-as-first-sirna-therapy-for-rare-lipid-disorder-F4VZWLISQVACJEJ4I5ZAEXUMN4/2026-04-24T16:53:55.708Zalways0.5https://insights.citeline.com/resizer/jMEms-mFlDkPkTC9DwO-1LaMmE4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/PHEF5HMBQRAI3HFXQYHUABIO6M.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/approval-standards/rfk-jr-hearings-preview-of-congressional-oversight-focus-after-mid-term-elections-ZFCXERBLV5CNDPCBXK54EKJ5J4/2026-04-24T16:20:50.531Zalways0.5https://insights.citeline.com/resizer/zVM5evohqLNbho_JxMGteTtPfys=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3LH372A7F5FTRJ7NQMM55QLOHQ.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/recalls/fda-issues-early-alert-on-medline-syringes-WN4P2IXNH5ABFMZKTNF4N4VN5U/2026-04-24T16:06:41.559Zalways0.5https://insights.citeline.com/resizer/9MTkME7oMYrMXtAnWxR8l0j4CTo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FNF4S7MRJFFF7LCJJBOJASJ7IE.jpghttps://insights.citeline.com/pink-sheet/product-reviews/us-advisory-committees/recent-and-upcoming-us-fda-advisory-committee-meetings-YLA6SZESNVCVNE26KRPTWJ5FVA/2026-04-24T15:54:22.72Zalways0.5https://insights.citeline.com/resizer/zK-1qhNmlz4zZcY6O0wKSeyretY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RGEVRT2KERADXPSY5GK6MDEY7M.jpghttps://insights.citeline.com/generics-bulletin/products/biosimilars/biocon-secures-health-canada-approval-for-two-denosumab-biosimilars-RZ2V4CF7KRAO5JJIQCN6HGB26Q/2026-04-24T15:11:04.943Zalways0.5https://insights.citeline.com/resizer/mcclyYhbYGq3RmlXsJRSVY8l-58=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IZWJVIY2IFBEPP7CB6M6AB2KVE.jpghttps://insights.citeline.com/medtech-insight/geography/europe/eu-unlocks-new-funding-for-health-ai-projects-4YWZ6N2SHJCIZE5VR7OENLKLUI/2026-04-24T15:08:50.232Zalways0.5https://insights.citeline.com/resizer/BmGervgWDhepZZQ--Xmnfl6axPI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FT7A6YTZFRJ6HIQXFLAZVMIZN4.jpghttps://insights.citeline.com/generics-bulletin/legalandip/europe-widens-competition-path-for-generic-peptides-UDPNQE4KQNH2VCU6UVRMEFMTJI/2026-04-24T14:48:33.437Zalways0.5https://insights.citeline.com/resizer/oVVJVpG41HfbT6Mu-xgYZviRVgM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HWGKHOWNEZHWLAYYSDNNC6BKA4.jpghttps://insights.citeline.com/generics-bulletin/products/generics/eu-nod-arrives-for-viatriss-ibrance-rival-QFEHF7NFXBBQFG2VM2IQ2N3JLY/2026-04-24T14:43:25.09Zalways0.5https://insights.citeline.com/resizer/C-kDWasJ-L1HGRfgeEdrX5i4ufs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GGWTS7PAONOYDEX24WQYHJDXGI.jpghttps://insights.citeline.com/hbw-insight/beauty/business/earnings/interparfums-navigating-more-selective-consumers-as-q1-sales-rise-OS3LWRGAZREADDNK6L7FGIODWE/2026-04-24T14:33:03.015Zalways0.5https://insights.citeline.com/resizer/5Fv1ZFyO7U6qiXhgegZ66wF7VWQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5RECXNPWYBEJNA2GUZJMKMP42E.jpghttps://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-twelve-approvals-and-nine-phase-iii-readouts-K42IQQCODZGAXN4LD6ISLTS5UQ/2026-04-24T14:11:11.176Zalways0.5https://insights.citeline.com/resizer/ImR5GTpVdBHGHf7TcvS_mtsKATo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ESZMBZ2PYRKC7MS7AXLRQU4VXA.jpghttps://insights.citeline.com/generics-bulletin/business/manufacturing/towa-builds-further-backup-network-for-drug-shortages-VJQTK3FNYFFIRA5JAHR2WLI53E/2026-04-24T11:49:52.328Zalways0.5https://insights.citeline.com/resizer/x33rq9rN2pTyVwPBUAV-J24-IvE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XFCZ3FMKSJISFIQ4HGOEENDGUY.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/reducing-uncertainty-in-early-oral-drug-development-decisions-that-benefit-from-predictive-insights-FS4MVISAPVD3VPKCW7BJHHPOU4/2026-04-24T11:44:59.459Zalways0.5https://insights.citeline.com/resizer/xcW5Ju6Ty0ZSR1wYHZ0s95mB9gk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/EVVSPOMIJ5GFNE23TCQJUU2FQY.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/guided-by-vision-redefining-osd-development-through-foresight-and-innovation-TRJQ5NJLWVC4LGZBGM3BQ4N4II/2026-04-24T11:43:53.466Zalways0.5https://insights.citeline.com/resizer/iF7wbGtwADyOq2uklR4EOLbsbQI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/35B6YVMNGBECZOSRQBWIWAT7OI.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/scaling-biologics-from-late-stage-development-to-commercialization-PCVRWYDUVFHZNE6AER2UQ6JROI/2026-04-24T11:42:39.448Zalways0.5https://insights.citeline.com/resizer/6X0TorFEuIdLk7RW4suqTHeDBFY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/VQIR7IK5OVFH3BONFSBDKYOVVY.pnghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/accelerator-drug-development-streamlining-preclinical-pathways-for-a-fast-transition-to-first-in-h-BQZYIXZIYRDLFBLJZQSLV6MTKA/2026-04-24T11:41:22.961Zalways0.5https://insights.citeline.com/resizer/SLUACXoQl4r1b1Z635X9xnVcYZs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LIC6URVE25EAHGBO546BV374WY.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/early-phase-injectable-formulation-development-HKROTVWRFFDFBD5HYYBNVIXT6Y/2026-04-24T11:37:34.04Zalways0.5https://insights.citeline.com/resizer/hvO8eQEE1KeE2FAaUZU4VbOVoVY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7I23Z3YIG5DGDPK4KCIO6VQYYA.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/clinical-supply-flexibility-where-biotech-programs-need-it-most-PJLVQGQ66VHFNC7XQPZ5UTEG7Y/2026-04-24T11:31:13.734Zalways0.5https://insights.citeline.com/resizer/1nzKkoZ0tFzgB37wQo-uUoC9u74=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JZCBQ64JX5CVHB5F7EIRPHPKCA.jpghttps://insights.citeline.com/scrip/market-access/bayer-pledges-loyalty-to-europe-but-demands-more-support-PPRC2JGNQNAHPL6PHEUNUHUJLY/2026-04-24T11:00:54.356Zalways0.5https://insights.citeline.com/resizer/DL29Xt69f0t0NXp0uxX9euvoCiM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WFG62U77QFH2JLF2YCJULWIKMY.jpghttps://insights.citeline.com/scrip/business/legalandip/astellas-settles-another-mirabegron-lawsuit-with-msn-pharma-KPS6YTUSBND5FL45EHWPSJJU24/2026-04-24T09:31:40.55Zalways0.5https://insights.citeline.com/resizer/IkCpB4x3i4ya8kjRILz0kcfyvAE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6X2MP4RMKRGDTLBDJ6FZH5BSIE.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/eu/ai-medtech-regulation-in-limbo-after-eu-rules-simplification-XLJXY5H45ZHDTIGCDZBC4RRUAY/2026-04-24T09:31:40.493Zalways0.5https://insights.citeline.com/resizer/iklEGrqK4B3Mo1zvu3jcLRw1fSY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XIDGMQGNB5AXRJJR7HOAFKT4X4.jpghttps://insights.citeline.com/scrip/business/earnings/ipsen-bets-on-pipeline-catalysts-and-rare-disease-momentum-to-power-2026-growth-HXTSUJGKUFBQFNFCGC4APZU3JM/2026-04-24T09:22:15.393Zalways0.5https://insights.citeline.com/resizer/Hq96Zf5YFVDC6VPXFygLpI2ZQmM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HAKIBX3K5RE6JHLHZIHBVAFAGU.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/compliance/imdrf-ai-framework-could-alter-cost-of-compliance-NJEZEI7IA5CPVE4I663K3IFE3Q/2026-04-24T08:38:08.902Zalways0.5https://insights.citeline.com/resizer/Idfv3I00i7jPoKTgLZZIKI5WKZY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/W6DZ5O7T3FB75DXRTT3A7W6TU4.jpghttps://insights.citeline.com/medtech-insight/business/earnings/thermo-fisher-raises-guidance-as-q1-results-dodge-tariff-concerns-6F7ZSQWNLRCFLJB6Y5564FVDUA/2026-04-24T08:33:32.587Zalways0.5https://insights.citeline.com/resizer/Hrx3LxYhAcMykSk63lz7fXqqOyw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/24YDLBG3YBJ3JONSKX76OCE6UM.jpghttps://insights.citeline.com/pink-sheet/market-access/government-payers/medicare/balance-model-delay-may-lead-to-revisions-higher-near-term-medicare-costs-B4LSH6CVIVGNRIPNVL5JIOR7YQ/2026-04-24T08:24:43.335Zalways0.5https://insights.citeline.com/resizer/8Bc-QR8-PBB_u1TPiqlw-2adyos=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JCLPB4PCYFDR7BBMJTR4ZWBCGQ.jpghttps://insights.citeline.com/pink-sheet/market-access/pricing-debate/germanys-higher-drug-rebates-would-send-the-wrong-message-to-pharma-GHEDMDIBVBATTGOLHEPLJUANHM/2026-04-24T08:03:49.348Zalways0.5https://insights.citeline.com/resizer/5T12wzxKcS2zznZY6r-rHPmVmXo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GYXRJ2Q3PFGL3MOXOBNJOPF2KE.jpghttps://insights.citeline.com/pink-sheet/biosimilars-and-generics/generics/gdufa-iv-industry-could-lower-application-fees-by-raising-program-fees-6IXCSAUL2FHWBCMF5QYXXNEBGU/2026-04-24T08:02:12.026Zalways0.5https://insights.citeline.com/resizer/Gv_OElJaTVPupnOv-IzYBA0yC3w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2X3OLDEYHJE3FGMNQVBWDE6NF4.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/complex-trials-clash-with-eu-ctis-translation-fix-on-patient-facing-documents-ALQ6CCEFBVG5HBV5YQJVMIQBK4/2026-04-24T08:00:56.279Zalways0.5https://insights.citeline.com/resizer/FzymdmHeN0cLCuhyh7eXiaDxk7k=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DKUHOAM4QBGZHDZXZA2O5TSPZ4.jpghttps://insights.citeline.com/pink-sheet/r-and-d/stripped-down-psychedelic-therapies-get-ready-for-a-gold-rush-us-dea-opens-door-for-marijuana-U6KB5EC67NGCLKCFDQY4LLSH7E/2026-04-24T07:59:42.259Zalways0.5https://insights.citeline.com/resizer/_B5Bdp9yCFu_HxmBpeAEiYpOUg4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/J63HZAO3OVAFZKK5JPK2IJPFXA.jpghttps://insights.citeline.com/pink-sheet/market-access/pricing-debate/double-billing-regeneron-mfn-deal-announced-along-with-approval-of-its-gene-therapy-CEMJNLG2FJHNLDF2VXH3PGBEPE/2026-04-24T07:57:34.807Zalways0.5https://insights.citeline.com/resizer/riHUNruLLlcT3zW7GzaJE_xgnAw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/42T7HZHBKFEHPOZA6PGBSOCHII.jpghttps://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-KROBJCLAKVFBLCZ7BGBGCE3VDQ/2026-04-24T06:30:24.914Zalways0.5https://insights.citeline.com/resizer/yYwvRVmhblLIMA0HOvUK6LfqRwQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/G7XLNG5DWRIZTCTW357HEKFDOE.jpghttps://insights.citeline.com/hbw-insight/health/policy-and-regulation/regulation/us-fda-looks-beyond-monoclonal-antibodies-to-encourage-animal-testing-alternatives-EPWPJ5BZLFCOPNYINN542XBP6Y/2026-04-24T02:51:58.022Zalways0.5https://insights.citeline.com/resizer/XjEK8yy69rYtmYy1v22n4bKexI4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/B4SYG2UZARFO5A6Q52RJRIOOP4.jpghttps://insights.citeline.com/hbw-insight/wellness/us-consumer-health-news-digest-business-regulation-science-HQRBLL5ETVCW5N67LU5S2A6MRI/2026-04-24T02:44:34.615Zalways0.5https://insights.citeline.com/resizer/uU0Rs_MxL-XVJjL4G2vjpgCJqkc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BKVVYHB6L5E2LDJ6P4RRH5HDGE.jpghttps://insights.citeline.com/companies/tianjin-botai-pharmaceutical-technology-co-ltd/2026-04-24T00:05:52.004Zalways0.5https://insights.citeline.com/companies/sino-biotech-co-ltd/2026-04-24T00:05:38.126Zalways0.5https://insights.citeline.com/companies/ionetix-corp/2026-04-24T00:05:21.903Zalways0.5https://insights.citeline.com/companies/shandong-baoli-steroid-biotechnology-co-ltd/2026-04-24T00:05:15.958Zalways0.5https://insights.citeline.com/companies/anova-innovation-limited/2026-04-24T00:05:09.946Zalways0.5https://insights.citeline.com/scrip/business/deals/deal-watch/deal-watch-first-quarter-posted-high-volume-dollar-value-in-alliance-deals-GOYNJTCAHBEFHNJNO26R6UUWEU/2026-04-24T00:05:07.973Zalways0.5https://insights.citeline.com/resizer/YSAhbXrw986f9cVmB617i4mwnCg=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FTTFPWM6YZML7OAZFQCNEZZKAA.jpghttps://insights.citeline.com/companies/hangzhou-baixin-biopharmaceutical-technology-co-ltd/2026-04-24T00:05:03.957Zalways0.5https://insights.citeline.com/companies/qingdao-cryowise-biotechnology-co-ltd/2026-04-24T00:04:57.849Zalways0.5https://insights.citeline.com/companies/shanghai-resthetic-biotech-co-ltd/2026-04-24T00:04:51.742Zalways0.5https://insights.citeline.com/companies/phoenix-labs/2026-04-24T00:04:45.774Zalways0.5https://insights.citeline.com/companies/clinactiv-holdings-inc/2026-04-24T00:04:39.827Zalways0.5https://insights.citeline.com/companies/shanghai-xiniao-biotechnology-co-ltd/2026-04-24T00:04:33.7Zalways0.5https://insights.citeline.com/companies/semarion/2026-04-24T00:04:27.678Zalways0.5https://insights.citeline.com/companies/gerotherapeutix/2026-04-24T00:04:21.733Zalways0.5https://insights.citeline.com/companies/theianova-ltd/2026-04-24T00:04:15.618Zalways0.5https://insights.citeline.com/scrip/business/earnings/ousted-hudson-hailed-as-sanofi-enters-new-era-with-ceo-garijo-ZAKTDKADF5EGRMAFG7YIPVVGHQ/2026-04-24T00:04:13.789Zalways0.5https://insights.citeline.com/resizer/tbryf4guH1gyJOQRNdA3v_jVjZo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WILCIH5L2ZG7FLYFSFN6EJQEV4.pnghttps://insights.citeline.com/companies/vyluma/2026-04-24T00:04:09.582Zalways0.5https://insights.citeline.com/companies/coagusense-inc/2026-04-24T00:04:03.473Zalways0.5https://insights.citeline.com/scrip/business/earnings/launch-momentum-in-the-spotlight-heading-into-q1-se-QF5F3SLLWJCH5JX3NLP2DXFNBU/2026-04-24T00:03:57.928Zalways0.5https://insights.citeline.com/resizer/2O89mU385P_QGpnTcFaR8yDspig=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QKYDXJA3HJHDXE6CNZOOJA4EP4.jpghttps://insights.citeline.com/companies/oxipitai/2026-04-24T00:03:51.544Zalways0.5https://insights.citeline.com/companies/hasten-biopharmaceuticals-sg-pte-ltd2026-04-24T00:03:45.676Zalways0.5https://insights.citeline.com/companies/maipl-therapeutics-inc2026-04-24T00:03:39.405Zalways0.5https://insights.citeline.com/companies/ophidion-inc2026-04-24T00:03:33.61Zalways0.5https://insights.citeline.com/companies/rinuagene-biotechnology-co-ltd2026-04-24T00:03:27.562Zalways0.5https://insights.citeline.com/companies/cohen-global-ltd2026-04-24T00:03:21.354Zalways0.5https://insights.citeline.com/companies/horizon-surgical-systems-inc2026-04-24T00:03:15.33Zalways0.5https://insights.citeline.com/companies/kailera-therapeutics2026-04-24T00:03:09.342Zalways0.5https://insights.citeline.com/companies/adovate-llc2026-04-24T00:03:03.462Zalways0.5https://insights.citeline.com/companies/the-whiteoak-group2026-04-24T00:02:57.325Zalways0.5https://insights.citeline.com/companies/quidelortho-corporation2026-04-24T00:02:51.321Zalways0.5https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-three-ceos-four-cmos-and-five-cfos-among-this-weeks-changes-SJ5ZD6T6ZREZZPM2OTORWRA5MM/2026-04-24T00:02:50.331Zalways0.5https://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpghttps://insights.citeline.com/companies/nectero-medical-inc2026-04-24T00:02:45.291Zalways0.5https://insights.citeline.com/scrip/business/earnings/roche-reaffirms-faith-in-breast-cancer-and-obesity-prospects-HKX4ZEX47VBHNP2P73FHCGM2PQ/2026-04-24T00:02:43.628Zalways0.5https://insights.citeline.com/resizer/M_NF1B9eVkriJYjwFIleiYEXYnw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FBFGUA43O5GRBLXACBS6KG3WTE.jpeghttps://insights.citeline.com/scrip/drug-pricing/double-billing-regeneron-mfn-deal-announced-along-with-approval-of-its-gene-therapy-KSYYXL3HABC7PE4UH2RVXQEIRA/2026-04-24T00:02:40.896Zalways0.5https://insights.citeline.com/resizer/riHUNruLLlcT3zW7GzaJE_xgnAw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/42T7HZHBKFEHPOZA6PGBSOCHII.jpghttps://insights.citeline.com/companies/neurona-therapeutics-inc2026-04-24T00:02:39.349Zalways0.5https://insights.citeline.com/companies/gilardoni-spa2026-04-24T00:02:33.156Zalways0.5https://insights.citeline.com/companies/sectra-ab2026-04-24T00:02:27.146Zalways0.5https://insights.citeline.com/companies/medix-biochemica2026-04-24T00:02:21.28Zalways0.5https://insights.citeline.com/companies/centene-corporation2026-04-24T00:02:15.063Zalways0.5https://insights.citeline.com/companies/university-of-notre-dame2026-04-24T00:02:09.031Zalways0.5https://insights.citeline.com/companies/alcami-corporation2026-04-24T00:02:03.052Zalways0.5https://insights.citeline.com/companies/cathworks-ltd2026-04-24T00:01:56.899Zalways0.5https://insights.citeline.com/companies/realta-life-sciences-inc2026-04-24T00:01:50.971Zalways0.5https://insights.citeline.com/companies/nuvoair-ab2026-04-24T00:01:44.878Zalways0.5https://insights.citeline.com/companies/celularity-inc2026-04-24T00:01:38.922Zalways0.5https://insights.citeline.com/companies/everest-medicines-limited2026-04-24T00:01:32.893Zalways0.5https://insights.citeline.com/companies/stablecoin-development-corporation/2026-04-24T00:01:12.096Zalways0.5https://insights.citeline.com/companies/purple-biotech-ltd2026-04-24T00:00:59.843Zalways0.5https://insights.citeline.com/companies/medtronic-plc2026-04-24T00:00:47.816Zalways0.5https://insights.citeline.com/companies/evotec-se2026-04-24T00:00:36.253Zalways0.5